MedPath

Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4

Not Applicable
Recruiting
Conditions
Intraventricular Hemorrhage of Prematurity
Hydrocephalus
Registration Number
NCT06797219
Lead Sponsor
Rutgers, The State University of New Jersey
Brief Summary

The primary purpose of this study is to serve as a pilot study of the EFIL device treatment feasibility of IVH grades 3,4 to guide development of a larger trial. Primary outcomes will assess the following: safety of intervention, recruitment and consent process, acceptability of intervention by parents, retention rates, selection of most appropriate outcome measures, provide sample size estimates for a larger trial, increase the researchers\' experience with the study intervention. A complete list of objectives and aims are listed under "Objectives". This study hopes to treat 12-24 neonates using 650nm light of irradiance 10mW/cm2 for 5 minutes twice a day each day for 12 days. We will also call the parents at 6 months and 12 months to track developmental milestones.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • neonates with intraventricular hemorrhage grade 3 or 4 less than 1 month old.
Exclusion Criteria
  • neonates without IVH grade 3/4 or older than 1 month.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Hemorrhage Resorption RateHemorrhage resorption rate tracking starts from date of identified intraventricular hemorrhage on head ultrasound (usually within 1 week of life) and head ultrasounds weekly up to 4 months old

Measure rate at which neonate intraventricular hemorrhage is resorbed via serial head ultrasounds

Neurosurgical InterventionsNumber of neurosurgical interventions starts at birth and continues up to 4 months old

number of patients requiring neurosurgical intervention

Anterior Horn WidthVentricle volume tracking starts from date of identified intraventricular hemorrhage on head ultrasound (within 1 week of life) performed through weekly head ultrasounds up to 4 months old

Measure rate at which neonate intracranial pressure changes using anterior horn width (mm) derived from serial head ultrasounds.

Neurodevelopmental Outcomes at 6 months and 12 months of ageTwo time points at 6 months of age and 12 months of age

A phone survey will be conducted inquiring which developmental milestones have been met at 6 months (i.e., sitting independently, reaching to grab toys, knows familiar people, takes turns making sounds with care giver) and 12 months (plays interactive games, says mama/dada, looks for hidden objects, cruises, pincer grasp)

Ventricular IndexVentricle volume tracking starts from date of identified intraventricular hemorrhage on head ultrasound (within 1 week of life); and subsequent weekly head ultrasounds performed up to 4 months old

Measure rate at which neonate intracranial pressure changes using ventricular index (mm) derived from serial head ultrasounds.

Head CircumferenceHead Circumference tracking starts from birth and is performed daily up to 4 months old

Measure rate at which neonate intracranial pressure changes via head circumference (cm).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Rutgers - New Jersey Medical School / University Hospital

🇺🇸

Newark, New Jersey, United States

Newark Beth Israel Medical Center

🇺🇸

Newark, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath